TransCode Therapeutics, Inc. (NASDAQ:RNAZ) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Elizabeth Czerepak Other companies: Delcath Systems, Inc. (DIRECTOR · Since at least Feb 14, 2020); Scilex Holding Company (See Remarks · Nov 10, 2022 – Jan 17, 2023 · Past); Sorrento Therapeutics, Inc. (EVP & Chief Financial Officer · Nov 15, 2021 – May 18, 2022 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 19, 2019 – Jun 18, 2020 · Past) | CFO, Director · Since at least Oct 6, 2025 |
| Anna Moore | Chair of Scientific Advisory Board · Since at least Apr 27, 2026 |
| Erik Manting | Director · Since at least Nov 5, 2026 |
| Jack E. Stover | Director · Since at least Dec 22, 2025 |
| John Tattory | Interim CFO · Since at least Sep 10, 2026 |
| Karrie Hilsinger | VP of Clinical Operations · Since at least Nov 4, 2026 |
| Magda Marquet | Director · Since at least Dec 22, 2025 |
| Michel Janicot | Consulting Head of Translational Science · Since at least Nov 17, 2025 |
| Philippe Calais | CEO · Since at least Oct 28, 2026 |
| Tania Montgomery-Hammon | VP, Business Development · Since at least Oct 13, 2026 |
| Zdravka Medarova | Cofounder/Chief Scientific Officer · Since at least Oct 19, 2026 |